ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Pyroptosis-Related Subtypes Predict the Response of Clear Cell Renal Cell Carcinoma to Targeted Therapy

Ma, Jinpeng; Kang, Zhijian; Yang, Guang; Wang, Xinyue; Si, Minggui; Wang, Yuting; Li, Guangbin; Bai, Shiyu; Zeng, Fanshu; Li, Min; Wang, Ziqi*; Wang, Lu*; Xu, Wanhai*哈尔滨医科大学; 1
Frontiers in Bioscience-Landmark2023-12DOI: 10.31083/j.fbl2812334
10阅读
引用收藏
分享

摘要

Background: Pyroptosis plays a crucial role in anti-tumor immunity and in formation of the immune microenvironment. However, whether pyroptosis is involved in the progression of clear cell renal cell carcinoma (ccRCC) is still unclear. Personalized treatment of ccRCC requires detailed molecular classification to inform a specific therapy. Methods: Molecular subtyping of ccRCC was performed based on consensus clustering of pyroptosis-related genes. The characteristics of these molecular subtypes were explored at the genome, transcriptome and protein levels. Single-cell RNA sequencing and CIBERSORT analysis were used to analyse the immune microenvironment of ccRCC, while Lasso regression was used to develop a prediction model based on hub genes. Expression of the pyroptosis-related gene GSDMB was also investigated at the tissue and cellular levels. Results: Two molecular subtypes were identified based on the clustering of pyroptosis-related genes. Cluster 1 was associated with activation of classical oncogenic pathways, especially the angiogenesis pathway. Cluster 2 was associated with activation of immune-related pathways and high levels of immunosuppressive cells, exhausted CD8+ T cells, and tumor-associated fibroblast infiltration. Clusters 1 and 2 were thus defined as the angiogenic and inflamed subtypes, respectively. The two subtypes were predictive of the response of ccRCC to anti-angiogenic therapy and immunotherapy, with Cluster 1 patients benefiting from anti-angiogenic therapy and Cluster 2 patients showing better response to anti-PD1 inhibitor therapy. Furthermore, a 9-gene expression signature (HJURP, NUF2, KIF15, MELK, TPX2, PLK1, CDCA3, CTLA4, FOXP3) was identified that could predict outcome and response to immune checkpoint blockade therapy in test cohorts. Finally, GSDMB was found to be involved in the development of renal clear cell carcinoma. Conclusions: These results on pyroptosis-related genes in ccRCC provide a theoretical basis for understanding molecular heterogeneity and for the development of individualized treatment strategies.

学科与关键词

关键词
pyroptosisimmune microenvironmentimmunotherapyclear cell renal carcinoma
相关
加载中…
  • Identification of pyroptosis-related subtypes and comprehensive analysis of characteristics of the tumor microenvironment infiltration in clear cell renal cell carcinoma
    Zeng, Jiayi; Zhu, Ping; Tang, Yanlin; Zhang, Changzheng; Ye, Chujin; Cheng, Shouyu; Tian, Kaiwen; Yang, Bowen; Zeng, Weinan; Liu, Yanjun*; Xian, Zhiyong*; Yu, Yuming*Scientific Reports, 2023, 13(1): 16055.
  • A pyroptosis-associated signature plays a role in prognosis prediction in clear cell renal cell carcinoma
    Li, Zhiyuan; Xia, Zhinan; Yu, Yipeng; Cai, Licheng; Jian, Wengang; Wang, Tengda; Xue, Wei; Wang, Xingyuan; Wang, Bowen; Zhang, Peng; Yao, Wenhao; Zhang, Cheng*; Wang, Chunyang*BMC Medical Genomics, 2022, 15(1): 204.被引 3
  • A Predictive Model Based on Pyroptosis-Related Gene Features Can Effectively Predict Clear Cell Renal Cell Carcinoma Prognosis and May Be an Underlying Target for Immunotherapy
    Wang, Yufu; Liu, Jinhui; Zhang, Lishuo; Li, Yifei*DISEASE MARKERS, 2022, 2022: 6402599.
查看全部 →

发表信息

论文状态
公开发表
期刊
Frontiers in Bioscience-Landmark
发表日期
2023-12
卷期
第 28 卷, 第 12 期
页码
334
DOI
10.31083/j.fbl2812334
语言
ENGLISH
成果收录
SCIE
资助标注
National Natural Science Foundation of China [82172000, 81971135, U20A20385]; Natural Science Foundation of Gansu Province [21JR11RA172]

作者

  • M

    Ma, Jinpeng (第一作者)

    harbin med univ

  • K

    Kang, Zhijian

    harbin med univ

查看全部 13 位作者收起作者
  • Y

    Yang, Guang

    1 · harbin med univ

  • W

    Wang, Xinyue

    harbin med univ

  • S

    Si, Minggui

    harbin med univ

  • W

    Wang, Yuting

    harbin med univ

  • L

    Li, Guangbin

    harbin med univ

  • B

    Bai, Shiyu

    harbin med univ

  • Z

    Zeng, Fanshu

    harbin med univ

  • L

    Li, Min

    harbin med univ

  • W

    Wang, Ziqi (通讯)

    harbin med univ

  • W

    Wang, Lu (通讯)

    harbin med univ

  • X

    Xu, Wanhai (通讯)

    harbin med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417